FRESENIUS KABI USA FDA Approval ANDA 210356

ANDA 210356

FRESENIUS KABI USA

FDA Drug Application

Application #210356

Application Sponsors

ANDA 210356FRESENIUS KABI USA

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 5MG BASE/ML0HALOPERIDOLHALOPERIDOL LACTATE

FDA Submissions

UNKNOWN; ORIG1AP2019-07-01STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210356
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"HALOPERIDOL","activeIngredients":"HALOPERIDOL LACTATE","strength":"EQ 5MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/01\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-07-01
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.